Slow hydroxylation of nortriptyline and concomitant poor debrisoquine hydroxylation: clinical implications

Lancet. 1981 Mar 7;1(8219):560-1. doi: 10.1016/s0140-6736(81)92894-4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Debrisoquin / metabolism*
  • Female
  • Humans
  • Hydroxylation
  • Isoquinolines / metabolism*
  • Nortriptyline / adverse effects
  • Nortriptyline / blood*
  • Phenotype

Substances

  • Isoquinolines
  • Nortriptyline
  • Debrisoquin